New HHS Secretary Becerra considered ‘friend of long-term care causes’ … U.K. nursing home staff passed B117 COVID variants to residents in early winter, study finds … 1 in 3 older thyroid disease...
Clinical briefs for Thursday, July 29
By
Alicia Lasek
Jul 29, 2021
Some Florida nursing homes limit visitation as COVID-19 cases triple … More LTC operators require vaccination for staff as new coronavirus variants raise infections rates … CDC’s indoor mask mandate...
Clinical briefs for Monday, May 3
By
Alicia Lasek
May 03, 2021
Feds push combo therapy treatments in LTC to combat new COVID variants … People connections buoyed elders during pandemic, investigators say … Task force pinpoints eldercare services that drive up...
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Clinical briefs for Tuesday, Aug. 3
By
Alicia Lasek
Aug 03, 2021
SNF recovery threatened by spread of delta variant: LTC exec … Nursing home COVID-19 outbreaks rising again in hot spots … Massachusetts outbreak prompts CDC to suggest re-upped pandemic mitigation...
J&J’s COVID-19 vaccine 74 percent effective, real-world study finds
By
Alicia Lasek
Nov 04, 2021
Data from more than 8,800 vaccinated Mayo Clinic patients has found that a single dose of Johnson & Johnson’s COVID-19 vaccine reduces hospitalization in the face of widely circulating gene variants.
COVID vaccines lost some effectiveness in delta surge, ongoing CDC study finds
By
Alicia Lasek
Aug 25, 2021
The three federally sanctioned COVID vaccines have lost a “moderate” amount of effectiveness against SARS-CoV-19 ever since the delta gene variant became the predominant U.S. strain, the agency reports.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...